NewSelf logo

NewSelf Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.7/10

Best for: semaglutide from about $100 a month at any dose, if a three-month commitment suits you

8.7
★★★★☆8.7/10

NewSelf falls below our bar on oversight: the FDA has issued it a warning letter. Its compounded semaglutide costs $100 a month, 50% below the $199 median among the sellers we compare.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

$100/mo
Same price at every dose

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

See plans →

Prices checked October 2026

Compare top-rated alternatives ↓

NewSelf prices its compounded GLP-1 blends from $99.97 a month for semaglutide (with B12 or glycine) and $144.49 for tirzepatide (with B6 or glycine), flat across doses. Each weight-loss plan locks in three months, and quitting early triggers a charge of one full retail month. An FDA warning letter dated February 2026 cites its marketing of these drugs. It serves 48 states plus Puerto Rico and claims LegitScript certification.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
GLP-1 from $100/moPrice shown up frontFlat across dosesIncludes medication + consult48 states

Is NewSelf legit?

NewSelf is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate NewSelf 8.7/10 overall.

Is there a NewSelf promo or coupon code?

We know of no promo or coupon code for NewSelf. Its listed price is $100 a month. Coupon sites advertising "NewSelf discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.

See how NewSelf compares on our rankings of the best semaglutide providers and the best tirzepatide providers.

Vetted alternatives to NewSelf

9.0/ 10
Verified partner

YourEra

Best for: semaglutide at $99/month, well below the typical price

★★★★★9.0/10

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideNAD+LegitScript Verified
Get StartedRead full YourEra review →
9.1/ 10
Verified partner

Collective

Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top

★★★★★9.1/10

Editorial score · methodology

$59/mo+ membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.1/ 10
Verified partner

Sesame Care

Best for: oral orforglipron alongside the injectables

★★★★☆8.1/10

Editorial score · methodology

$149/mo+ care fee
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
NewSelf logo
8.7 / 10
Our editorial rating
Visit NewSelf →

from $100/mo · no insurance needed

NewSelf at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$100/mo (All dosages same price. Three-month commitment.)
Pricing model
Flat: the price stays the same as the dose goes up
What's included
Medication · Consult · Shipping
Availability
48 states
FDA status
1 FDA warning letter (details below)

How NewSelf scores

Six columns, each one computed from something NewSelf has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.

Value25%

10.0/10

$100/month is 50% below the $199 median for compounded semaglutide across the sellers we compare.

Effectiveness25%

10.0/10

Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).

User Experience15%

8.0/10

A price is shown before the questionnaire starts.

Trust & Safety15%

5.5/10

The FDA has issued it a warning letter. No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.

Accessibility10%

9.7/10

Serves 48 of 50 states.

Support10%

7.0/10

The price covers the medication, clinician visits and shipping.

6weighted dimensions
734sellers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →

What we checked on NewSelf

Last checked October 2026
  • Checked the listed price across 2 dose or plan tiers
  • Checked state coverage: 48 states
  • Checked what the monthly price covers, and what it leaves out
  • Checked FDA warning letters for NewSelf

Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.

What signing up with NewSelf involves

What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.

  1. 1NewSelf shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
  2. 2Ask NewSelf which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
  3. 3The monthly price includes the medication, clinician visits and shipping.
Price shown before you start
  • Lowest ongoing monthly price: semaglutide $100, tirzepatide $144. That leaves out membership fees, first-month rates and insurance copays.
  • NewSelf serves 48 of 50 states, so check that yours is one of them.
  • The FDA has issued NewSelf a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
  • The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.

Contacting NewSelf

Email
NewSelf offers email support
Hours
24/7

Cancelling NewSelf

Taken from the terms NewSelf publishes. Terms change, so check the current policy before you subscribe.

Cancel any time
No, a minimum commitment applies
Minimum commitment
3 months
Refund policy
None after the doctor visit; $99 fee if canceled before it; full refund if declined
Early-termination fee
Yes

Medications NewSelf lists

NewSelf lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.

Pricing

Prices re-verified

Semaglutide+ (as-low-as price; plan length shown only after signup)Compounded
$100/mo
semaglutide

All dosages same price. Three-month commitment.

Tirzepatide+ (as-low-as price; plan length shown only after signup)Compounded
$144/mo
tirzepatide

All dosages same price. Three-month commitment.

Check the price yourself before you pay

Every figure here comes from NewSelf's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.

See NewSelf pricing →

In its favor

  • Semaglutide costs $100 a month, 50% below the $199 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $144 a month, 46% below the $269 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves 48 states

Against it

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued NewSelf a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

What NewSelf charges

The standing price at NewSelf is $100/month, unchanged as the dose goes up. That sits at the affordable end of what we see. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.

  • Compounded semaglutide: $100/month
  • Compounded tirzepatide: $144/month

For compounded semaglutide, the median across the sellers we compare is $199/month, so NewSelf's $100 is genuinely below the middle, not just advertised that way. Before you pay, compare NewSelf's cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.

Oak, at about $100/month, is the closest like-for-like alternative we review.

What NewSelf dispenses

NewSelf prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.

Safety and disclosure

NewSelf tells you its price before you start the medical questionnaire, the 48 states it serves, and that its pharmacy is accredited. The FDA has issued NewSelf a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If NewSelf will not tell you, treat that as a warning sign. Across the market, the FDA's GLP-1 warning letters are mostly about what sellers said rather than what pharmacies made. How we weigh oversight, disclosure and price is set out in our scoring methodology.

Who should look elsewhere

  • You want the FDA-approved pen specifically. Everything listed here is compounded.
  • You need insurance to cover the cost. Check whether NewSelf bills your plan before you start.
  • A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.

It fits if

  • the lowest standing monthly cost is what you are solving for
  • you want the price to stop moving as your dose climbs

Our read

NewSelf competes on price, and at $100/month it competes well. The FDA warning letter is what to weigh against that, not a footnote to it. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.

The Bottom Line

NewSelf falls below our bar on oversight: the FDA has issued it a warning letter. Its compounded semaglutide costs $100 a month, 50% below the $199 median among the sellers we compare.

Score: 8.7/10Best for: semaglutide from about $100 a month at any dose, if a three-month commitment suits youFrom: $100/mo

Before you pay NewSelf

Starting at $100 a month. Check today's price, then start the intake.

Where NewSelf is the wrong choice

No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.

  • If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
  • If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
  • If you want a human checking in, not just a prescription, consider Eden.

If none of these fits, our guide to alternatives to NewSelf sets more sellers in the same category beside NewSelf on price, states and what the price includes.

Frequently Asked Questions

NewSelf prices its compounded GLP-1 blends from $99.97 a month for semaglutide (with B12 or glycine) and $144.49 for tirzepatide (with B6 or glycine), flat across doses. Each weight-loss plan locks in three months, and quitting early triggers a charge of one full retail month. An FDA warning letter dated February 2026 cites its marketing of these drugs. It serves 48 states plus Puerto Rico and claims LegitScript certification. We rate it 8.7/10 overall.
NewSelf starts at $100 a month. That number holds across doses, so titrating up does not move the bill. The pricing table above lists every tier.
NewSelf names 48 states. Check that yours is on the list before you go any further.
NewSelf lists compounded semaglutide and compounded tirzepatide.
NewSelf lists compounded GLP-1s only. A licensed compounding pharmacy prepares them: same active ingredient as the brand drug, lower cash price, and no FDA approval of the finished product. That last part is the one readers underestimate, and the review above says why.
Check whether NewSelf bills your insurance before you sign up. Compounded GLP-1s are rarely covered by insurance, so plan on paying the listed cash price.
NewSelf says the price covers medication, the clinician visit and shipping. The strip near the top of this review shows what is included and what is not.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. NewSelf runs that whole sequence on its own site.
The FDA warning letter is the one that matters, and it is summarized at the top of this review. Also weigh these before you buy: Ask which pharmacy fills the prescription before you pay, so you can check its license. Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Other sellers we cover include Oak, SnagRx, and Lttl. Which one fits depends on the medication, the monthly price you can sustain and whether it ships to your state, so compare those three facts before you switch.

How to check NewSelf yourself

Every seller that ships to your state, side by side: Alaska, Arkansas, Delaware, Montana, North Carolina, Pennsylvania, South Carolina, Wyoming and every other state.

Glossary

The words sellers use, defined. Tap any term.

Regulatory notice

NewSelf has an FDA warning letter on record, dated February 20, 2026

This letter concerns false & misleading claims/misbranded. A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.

Read the full letter →

Sources

Cited across this NewSelf review: primary regulatory filings, and peer-reviewed studies.

Sources & methodology — as of October 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.

See NewSelf's current pricing

Plans start at $100 a month. Whether you qualify is a clinician's decision, made after your intake.